Fate Therapeutics, Inc.FATENASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-23.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-23.7%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 13.66% |
| 2024 | 7.10% |
| 2023 | 46.71% |
| 2022 | -52.40% |
| 2021 | -315.18% |
| 2020 | 52.84% |
| 2019 | -115.20% |
| 2018 | -4.73% |
| 2017 | -23.75% |
| 2016 | -62.11% |